IMMUNITYBIO, INC. Active Patents
182 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2025-08-29: Application 19315259; Invention TREATMENT OF IMMUNOSUPPRESSED SUBJECTS; Applicant NantCell, Inc.; Status Patented Case.
- 2025-04-22: Application 19186092; Invention TREATMENT OF IMMUNOSUPPRESSED SUBJECTS; Applicant NantCell, Inc.; Status Patented Case.
- 2025-03-20: Application 19085903; Invention Compositions and Methods for NK-92 Cells Expressing Native CD16; Applicant ImmunityBio, Inc.; Status Patented Case.
- 2025-03-07: Application 19074288; Invention DISTRIBUTED LEDGER FOR MEDICAMENT ADMINISTRATION TRACKING; Applicant ImmunityBio, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-29 | 19315259 | TREATMENT OF IMMUNOSUPPRESSED SUBJECTS | NantCell, Inc. | Patented Case | 2026-09-15 | 12734216 | US20260124277A1 | Patrick Soon-Shiong | United States | COHEN, MICHAEL P |
| 2025-04-22 | 19186092 | TREATMENT OF IMMUNOSUPPRESSED SUBJECTS | NantCell, Inc. | Patented Case | 2025-09-30 | 12427184 | US20250249073A1 | Patrick Soon-Shiong | United States | COHEN, MICHAEL P |
| 2025-03-20 | 19085903 | Compositions and Methods for NK-92 Cells Expressing Native CD16 | ImmunityBio, Inc. | Patented Case | 2026-07-14 | 12681020 | US20250298030A1 | Barry J. Simon Laurent H. Boissel Prachi Jain | United States United States United States | LEITH, NANCY J |
| 2025-03-07 | 19074288 | DISTRIBUTED LEDGER FOR MEDICAMENT ADMINISTRATION TRACKING | ImmunityBio, Inc. | Patented Case | 2026-08-18 | 12712061 | US20250342930A1 | Patrick Soon-Shiong Nicholas J. Witchey | United States United States | SOREY, ROBERT A |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |